Tesamorelin is a recurring topic in our peptide coverage. This hub collects every article tagged Tesamorelin, newest first, each evidence-graded and tied to real, verifiable sources.
A clinical-evidence ranking of the peptides that actually reduce visceral (belly) fat — one of the rare peptide topics with genuine Grade A human RCT proof — separating the FDA-approved and investigational incretin/GHRH drugs from the gray-market 'fat-loss' peptides that have none.
A clinical, evidence-first ranking of the peptides marketed for the menopause transition — separating the one FDA-approved molecule from the population-borrowed, preclinical, and mechanistically backwards claims.
An evidence-first ranking of the GH secretagogues sold for 'growth hormone optimization' — tesamorelin, MK-677, CJC-1295, sermorelin and ipamorelin — separating what raises GH/IGF-1 in humans from what only sounds like it should.
A clinical monograph on tesamorelin (Egrifta / EGRIFTA WR) — the FDA-approved GHRH analog with genuine Grade-A human RCT evidence for visceral fat in HIV lipodystrophy, and an unproven non-HIV anti-aging market.
A clinical monograph on the tesamorelin + ipamorelin stack — a GHRH-analog plus ghrelin-receptor agonist combination marketed for body composition. Sound mechanism, Grade-A component data, but zero RCTs of the combination itself.
Tesamorelin is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Tesamorelin, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.